Trial Profile
An efficacy trial of istradefylline and repetitive transcranial magnetic stimulation (rTMS) in the treatment of parkinson's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 22 Jun 2016 New trial record